Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG

Keyphrases

• Randomized Trial 100%
• Rhabdomyosarcoma 100%
• Accelerated Radiotherapy 100%
• Conventional Fractionated Radiotherapy 83%
• Failure-free Survival 50%
• Overall Survival 41%
• Parameningeal 41%
• Radiotherapy 33%
• Tumor Size 25%
• Failure Rate 25%
• Conventionally Fractionated 25%
• Head-and-neck 25%
• Tumor 16%
• Chemotherapy 16%
• Survival Rate 16%
• Histopathological Features 16%
• Induction Chemotherapy 16%
• Tumor Invasiveness 16%
• Regional Failure 16%
• Distant Failure 16%
• Bladder/prostate 16%
• Primary Tumor 8%
• High Risk 8%
• Pathological Findings 8%
• Univariate Analysis 8%
• Young Age 8%
• Histology 8%
• Lymph Node 8%
• Nausea-vomiting 8%
• Mucositis 8%
• Treatment Methods 8%
• Progressive Disease 8%
• Cumulative Incidence 8%
• Twice Daily 8%
• Intent-to-treat 8%
• Standard of Care 8%
• Early Death 8%
• Medication Adherence 8%
• Overall Survival Rate 8%
• Control Failure 8%
• Local-regional Control 8%
• Modal 8%
• Group Finding 8%
• Treatment Assignment 8%
• Skin Reactions 8%
• Nodal Status 8%
• Local Failure 8%
• Toxicity Assessment 8%
• Hyperfractionated 8%
• Irradiated Patients 8%
• Feature Stage 8%
• Working Diagnosis 8%
• Good Outcome 8%

Medicine and Dentistry

• Rhabdomyosarcoma 100%
• Radiation Therapy 100%
• Overall Survival 23%
• Failure Free Survival 23%
• Neoplasm 19%
• Survival Rate 11%
• Neck 11%
• Bladder 7%
• Induction Chemotherapy 7%
• Tumor 7%
• Chemotherapy 7%
• Univariate Analysis 3%
• Primary Tumor 3%
• Lymph Node 3%
• Mucositis 3%
• Intention-to-Treat Analysis 3%
• Patient Compliance 3%
• Progressive Disease 3%
• Cumulative Incidence 3%
• Nausea and Vomiting 3%
• Skin Manifestation 3%
• Toxicity Assessment 3%
• Parental Death 3%
• Diseases 3%
• Histology 3%
• Median Follow Up 3%